Acetyl-l-carnitine deficiency in patients with major depressive disorder - Test2 - elhamkhani - TriplyDB

Acetyl-l-carnitine deficiency in patients with major depressive disorder

Acetyl-l-carnitine deficiency in patients with major depressive disorder

http://www.wikidata.org/entity/Q56148475

about

Acetyl-l-carnitine deficiency in patients with major depressive disorder

http://www.wikidata.org/entity/Q56148475

description

article published in the Proce ...... f the United States of America

@en

article publié dans les Procee ...... f the United States of America

@fr

im Juli 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@en

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@nl

type

label

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@en

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@nl

prefLabel

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@en

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@nl

P1433

Q56148475-2C31DB5B-BAE0-49D6-9EBE-6B6D4D323E51

P1476

Q56148475-1927C51E-4639-4404-A68D-8DB6AD8CC413

P2093

Q56148475-02DBA0C4-79B0-4255-93AD-9706C87E1046

Q56148475-09ED72CC-78DC-4194-B8EC-61367BFCA6B2

Q56148475-0B32FF0B-A186-4DA3-B1AB-7972FC9A33FF

Q56148475-16911049-4613-492B-B6A1-81DC67C9FD44

Q56148475-29B9795E-F024-40FA-96E4-D0319EFD10B9

Q56148475-2A9D7319-B3C9-48B3-A503-1094838171B4

Q56148475-359029DA-E4E6-4B8A-AB20-AA9562E8FCA8

Q56148475-47195982-AF5E-4DB5-8BC2-98BBD09FF57A

Q56148475-8808372F-E4DB-4B41-A84D-4851AAFD3FCD

Q56148475-988C649C-FB1C-4681-8BA7-EDB284629B47

P2860

Q56148475-0BCC1047-CD93-4EEC-BCD2-C0A2E6DE16F3

Q56148475-0C75E74F-B430-4866-996A-914C8B11302A

Q56148475-115A42DC-AA76-47C0-9870-8F859C19F0C9

Q56148475-12AE898C-A7B5-4AAD-AE94-4B95CF6BE3CD

Q56148475-1EE728E8-A321-4EEA-A28E-A7A96F5778D9

Q56148475-1F7A0918-FBB0-4391-83FF-C93C562FE618

Q56148475-245F683E-AC55-4737-9B0B-15C4EFFA8499

Q56148475-2C2A4932-0A76-4A23-AC1C-BEE7D6F9267E

Q56148475-2E3EDF37-79A0-43CC-8CFF-DC28A61DD674

Q56148475-320F9D36-6175-42F3-9BDB-993E1B0E8388

P304

Q56148475-6D809F88-3BD8-43EB-9BEC-08EF75787369

P31

Q56148475-F6A7F526-38C1-44BD-83F6-2F1D84CAD402

P356

Q56148475-EAD7974C-614F-4C09-875D-8B530AAE9694

P407

Q56148475-53DCE049-8C47-4BAA-9EB5-771301E3BAED

P577

Q56148475-31CD49B6-0ECA-4B8E-892B-09B46AA394E5

P698

Q56148475-0B0FB174-833A-4318-AFA2-ABD7CC23ACE2

P921

Q56148475-8ed56f05-4f4f-9e24-fe28-9ba6d32ad958

Q56148475-e256663b-4417-413c-f05d-bc29ac8f7db0

P932

Q56148475-B75547F7-DE51-4EE7-A93C-63EB7A5469AB

P356

PNAS.1801609115

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Acetyl-l-carnitine deficiency in patients with major depressive disorder

@en

P2093

Aleksander A. Mathé

http://www.w3.org/2001/XMLSchema#string

Ashly Albright

http://www.w3.org/2001/XMLSchema#string

Benedetta Bigio

http://www.w3.org/2001/XMLSchema#string

Bruce S. McEwen

http://www.w3.org/2001/XMLSchema#string

Carla Nasca

http://www.w3.org/2001/XMLSchema#string

David S. Millington

http://www.w3.org/2001/XMLSchema#string

Francis S. Lee

http://www.w3.org/2001/XMLSchema#string

James Beasley

http://www.w3.org/2001/XMLSchema#string

James H. Kocsis

http://www.w3.org/2001/XMLSchema#string

James W. Murrough

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of stress in the brain

Antidepressant actions of ketamine: from molecular mechanisms to clinical practice

A review of current evidence for acetyl-l-carnitine in the treatment of depression

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.

Epigenetic mechanisms of depression

The epidemiology of depression across cultures

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression.

Treatment-resistant depression.

P304

201801609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1801609115

http://www.w3.org/2001/XMLSchema#string

P407

P577

2018-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30061399

http://www.w3.org/2001/XMLSchema#string

P921

acetylcarnitine

mental depression

P932

6112703

http://www.w3.org/2001/XMLSchema#string